OBJECTIVE: To evaluate the threshold limit of vitamin D3 associated with the risk of nonskeletal health complications in humans. BACKGROUND: Vitamin D3 defi ciency is primary caused by a reduced sun exposure, consequent limiting of vitamin D3 production in the skin, and low intake of food with this vitamin. METHODS: Ninety-two adults (25-95 years old) were admitted to III. Internal clinic or examined in outpatient department of The University hospital in Bratislava. Vitamin D3 levels were determined using electrochemical luminescence immunoassay. The least square method for the results processing was used. RESULTS: Vitamin D3 level 16 ng/ml may be threshold limit for the risk of hypertension, ischaemic heart disease, renal insuffi ciency and diabetes mellitus. A higher occurrence of the observed diseases was in female and male patients with vitamin D3 levels<16 ng/ml.The highest increase of occurrence of diabetes mellitus in women for vitamin D3<16 ng/ml (160%) compared to vitamin D3≥16 ng/ml (40%) was observed. Concerning the men, the highest increase refers to ischaemic heart disease (67%). CONCLUSION: The limit value of vitamin D3, 16 ng/ml, confi rmed the association between vitamin D3 insuffi ciency and the presence of hypertension, ischaemic heart disease, renal insuffi ciency and diabetes mellitus. Its relation to age, sex and other variables was detected (Tab. 1, Fig. 5, Ref. 27 ).Text in PDF www.elis.sk.
Introduction
Vitamin D3 constitutes an essential substance in the prevention of cardiovascular diseases, diabetes mellitus, renal diseases, cancers, auto-immune diseases, fracture prevention and other human affections (1) (2) (3) . The effect of vitamin D mediated through the vitamin D receptor is more intensive to the metabolic functions, such as: the immune system, cell proliferation and differentiation, than from the viewpoint of the calcium metabolism control. Vitamin D has pleiotropic effects on immunity, endothelial and mucosal function and then vitamin D defi ciency may worsen pre-existing immune and metabolic dysfunction. The higher risk associated with vitamin D defi ciency was evident among individuals with a high blood pressure (4) .The defi ciency of vitamin D3 is primary caused by a reduced sun exposure, consequently limiting the vitamin D3 production in the skin and a low intake of food containing this vi-tamin. The Health Professional Follow-Up Study (5) found that men with a low level of vitamin D3 were twice as likely to have a heart attack as men with an adequate level of vitamin D3. Low vitamin D3 levels are associated with a higher risk of heart failure, sudden cardiac death, stroke, overall cardiovascular disease, and cardiovascular death (6) (7) (8) (9) . How exactly might vitamin D3 help to prevent the heart disease? There's the evidence that vitamin D3 plays a role in controlling blood pressure and preventing artery damage, and this may explain these fi ndings (10) . Type 1 diabetes mellitus varies with geography -a child in Finland is about 400 times more likely to develop this disease than a child in Venezuela (11) . Evidence that vitamin D3 may play a role in the prevention of type 1 diabetes comes from a 30-year study that followed Finnish children, where children, who regularly received vitamin D3 supplements during infancy had a nearly 90 percent lower risk of developing type 1 diabetes than those, who did not receive supplements (12) . Other European case-control studies also suggested that vitamin D3 might help to protect against type 1 diabetes (13). In the kidney,vitamin D3 may be important for maintenance of podocyte health, prevention of epithelial-to-mesenchyme transformation, suppression of renin gene expression and infl ammation (14) . Prevalence of the vitamin D defi ciency is 30-60 % of US and European population (4) . The defi ciency of vitamin D was considered one of the probable reasons of high mortality in Scotland between 1950 and 1980 (15) . Worldwide, the vitamin D3 defi ciencies can be found in the people of all continents, within all ethnic groups and/or ages. Some surveys suggest that almost a half of the world's population has inadequate blood levels of vitamin D3 (16) (17) (18) . World defi ned prevalent limit value of vitamin D3 for assessment of infl uence of vitamin D3 concentration on diagnosis is 30ng/ml. However, this limit is different in individual human populations of the world. Consequently, our work was aimed to detect the critical threshold for chosen age-and sex-heterogeneous group of patients, and to evaluate the association between vitamin D3 insuffi ciency and the presence of hypertension, ischaemic heart disease, renal insufficiency and diabetes mellitus in relation to age and other variables.
Materials and methods

Patients and methods
A group of 92 adult patients (25 -95 years old) was admitted to IIIrd Internal Clinic, Faculty of Medicine, Comenius University or examined in outpatient department of Derer´s University Hospital in Bratislava. The study was approved by the ethics committee and was conducted in accordance with the principles of the Declaration of Helsinki. The analyses of plasma blood samples were performed from April 2009 to October 2009. Vitamin D3 levels were determined using electrochemical luminescence immunoassay. Serum 25-hydroxycalciferolvitamin D levels ≤ 30 ng/ml were characterized as vitamin D3 insuffi ciency. The results were processed by the least squares method. Figure 1 showed the whole distribution of the tested group of patients according to the observed diagnoses.
Results
Based on the least squares method, the relationship between the plasma blood vitamin D3 concentration and the patients age and/or the seasons of the year was analyzed by a regression line in the form:
vitamin D3 (age) = 19.57−0.061΄ age ( Fig. 2 ) and/or regression parabola in the form: vitamin D3 (month) = −20.40+9.30΄ month−0.56΄ month 2 (Fig. 3 ), respectively. According to world considered prevalent limit 30 ng/ml, Figs 2 and 3 showed that 5% of the whole patients group had an adequate vitamin D3 blood concentration situated above this limit line, independently of the age or the season. However, 95% of the patients with vitamin D3 blood concentration situated on and below the prevalent limit line demonstrated the insuffi ciency of this vitamin. Regarding the tested patients and diseases, the results of the regression analyses indicated 16 ng/ml as a suitable limit value for assessment of vitamin D3 concentration infl uence on tested human diagnosis. Overall, 75% of adults from tested patients group had hypertension, 71% had ischaemic heart disease, 43% had renal insuffi ciency, 33% had diabetes mellitus, 95% of patients had vitamin D3 insuffi ciency.There was a higher occurrence of diseases in adults whose vitamin D3 levels were<16 ng/mL while both sexes were equally affected. Observed threshold limit is sustained also by comparison between the measured vitamin D3 concentration and the patient age ( Fig. 2 ) or the season (Fig. 3) . Figures 4 and 5 show detected a higher occurrence of diseases in female and male patients, respectively, with vitamin D3 levels < 16 ng/ml. Table 1 describes that the highest increase of occurrence of diabetes mellitus in women for vitamin D3 <16 ng/ml (160%) towards vitamin D3 ≥16 ng/ml (40%) was observed.
Concerning the men, the highest increase refers to ischaemic heart disease IHD (67%), where both sexes were equally affected. Consequently, 16 ng/ml of vitamin D3, as the threshold limit value for the risk of hypertension, ischaemic heart disease, renal insuffi ciency and diabetes mellitus, was observed. 
Discussion
According to the obtained results, the association between vitamin D3 insuffi ciency and the presence of hypertension, ischaemic heart disease, renal insuffi ciency and diabetes mellitus, even after adjustment for age, sex and other variables, was observed. The heart like skeletal muscle contains the receptors for vitamin D. Therefore, the relationship between the defi ciency of vitamin D and the heart diseases is evident. Despite the fact that world defi ned prevalent limit of vitamin D3 is 30 ng/ml, many scientifi c studies consider a different threshold for assessment of infl uence of vitamin D3 concentration in human diagnosis. Schwalfenberg et al (2010) stated that vitamin D suffi ciency was indicated by the standard 25(OH)D level of 75-80 nmol/l (i.e.30-32 ng/ml). Ashraf et al (2009) suggested that the concentration of 15 ng/ml or less might be the threshold, by which vitamin D3 defi ciency conferred negative effects on insulin sensitivity. According to De Boer et al (2012), the threshold concentrations associated with an increased risk for relevant clinical disease was near 20 ng/ml. According to Ginter and Simko (2009) , within European countries, serum 25(OH)D was <25 nmol/L in 2-30 % of adults and the defi ciency was increasing in elderly people.
The results of our analysis seem to be similar with previous works. The obtained results consider that 16 ng/ml may present the threshold limit for the risk of diabetes mellitus, hypertension, ischaemic heart disease and renal insuffi ciency. Urgent research and clinical priorities would be identifi ed, including reassessment of laboratory ranges for 25(OH)D, to avoid problems of both undertreatment and over-treatment (22) . Brazdilova et al (2012) detected a negative correlation between obesity and vitamin D3 levels, and a low vitamin D3 concentration in 90% of 55 tested patients with median 19.36 μg/l (64% measured in winter, 36% in summer). They observed no relationship between vitamin D3 levels and season, and a negative correlation between low vitamin D3 concentration and diabetes mellitus. Baykal et al (2012) determined a signifi cantly lower mean serum 25(OH)D levels in the patients with rheumatoid arthritis compared to the healthy subjects. Vitamin D serum levels lower than 20 ng/ml were observed in 72% of patients. According to Snellman et al (2010) , vitamin D is not only important for bone health, but can also affect the development of several non-bone diseases. The defi nition of vitamin D insuffi ciency by serum levels of 25-hydroxyvitamin D depends on the clinical outcome, but might also be a consequence of analytical methods used for the defi nition. Although numerous 25-hydroxyvitamin D assays are available, their comparability is uncertain. A high inter-assay disagreement was found. The mean 25-hydroxyvitamin D levels were highest for the HPLC-APCI-MS technique (85 nmol/L, 95% CI 81-89), intermediate for RIA (70 nmol/L, 95% CI 66-74) and lowest with CLIA (60 nmol/L, 95% CI 56-64). Using the 50-nmol/L cut-off, 8% of the subjects were insuffi cient using HPLC-APCI-MS, 22% with RIA and 43% by CLIA. The strongest correlation was found for HPLC-APCI-MS (r = 0.7), intermediate for RIA (r = 0.5) and lowest for CLIA (r = 0.4). Regression analyses between the methods revealed a non-uniform variance (p<0.0001) depending on the level of 25-hydroxyvitamin D. There were substantial inter-assay differences in performance. The most valid method was HPLC-APCI-MS. Calibration between 25-hydroxyvitamin D assays is intricate.
Bolland et al (2014) did a trial sequential meta-analysis of the existing randomized controlled trials of vitamin D supplements, with or without calcium, to investigate the possible effect of the future trials on the current knowledge. He estimated the effects of vitamin D supplementation on myocardial infarction or ischaemic heart disease, stroke or cerebrovascular disease, cancer, total fracture, hip fracture, and mortality in trial sequential analyses using a risk reduction threshold of 5% for mortality and 15% for other endpoints.
The effect estimated for vitamin D supplementation with or without calcium for myocardial infarction or ischaemic heart disease (nine trials, 48 647 patients), stroke or cerebrovascular disease These fi ndings suggested that vitamin D supplementation with or without calcium doesnot reduce skeletal or non-skeletal outcomes in unselected community-dwelling individuals by more than 15%. Long recognized as important for bone health, vitamin D has attracted recent interest for its possible non-skeletal benefi ts. Many primary care clinicians now include blood tests to measure vitamin D concentrations as part of routine laboratory work and recommend vitamin D supplements, often at high doses, to their patients for the possible prevention of cancer, cardiovascular disease, diabetes, autoimmune disorders, cognitive decline, and other conditions (27) .
Conclusion
The further studies of the relationship between vitamin D3 insuffi ciency and the presence of hypertension, ischaemic heart disease, renal insuffi ciency and diabetes mellitus may lead to the new interventions with decrease prevalence of non-skeletal effects of vitamin D3 in humans.
